In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / ...

To achieve this progress, biologic production has had to reinvent itself. Although biologics were once sourced directly from donated blood plasma or cells, the backbone of this process is now a ...

Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...

先端分野の市場情報を提供する株式会社グローバルインフォメーション（神奈川県川崎市、代表取締役社長：小野 悟）は、2014年5月20～23日 中国、上海にて開催 IBC Asia Limited主催 国際学会「Cell Line Development & Engineering Asia 2014-アジア細胞株開発 ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...

Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...

Catalent’s GPEx® Lightning platform delivers stable, high-yield cell lines with unmatched speed—achieving titers up to 15g/L for mAbs and 11g/L for bispecifics. With 25-day pool generation and up to ...